Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simin Mahinrad

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practiceClifford R Jack, Ana Graf, Samantha C Burnham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 22, 2024
Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagementDorene M Rentz, Paul S Aisen, Alireza Atri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroupEllis S van Etten, Simin Mahinrad, Joshua D Grill, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatmentB Joy Snider, Alessandro Biffi, Sasha Bozeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 28, 2026
Prevalence of dementia in selected Middle East and North Africa (MENA) countries: A systematic review and meta-analysisMohsen Sedighi, Mohammad Hasan Shahabi, Alireza Amanollahi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 5, 2025
Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: A systematic review and meta-analysisSarah Pahlke, Lara A Kahale, Simin Mahinrad, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2025
Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settingsSebastian Palmqvist, Heather E Whitson, Laura A Allen, et al.
Science Translational Medicine|November 5, 2025
Beyond Alzheimer's disease-translating biomarker insights across CNS diseasesLinda S Brady, Simin Mahinrad, Rebecca M Edelmayer, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2025
Tau biology, biomarkers, and therapeuticsBess Frost, Hartmuth Kolb, Alicia Algeciras-Schimnich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 15, 2026
Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)Philippe Amouyel, Sandrine Andrieu, Angela Bradshaw, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practiceClifford R Jack, Ana Graf, Samantha C Burnham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 22, 2024
Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagementDorene M Rentz, Paul S Aisen, Alireza Atri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2026
Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroupEllis S van Etten, Simin Mahinrad, Joshua D Grill, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatmentB Joy Snider, Alessandro Biffi, Sasha Bozeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 28, 2026
Prevalence of dementia in selected Middle East and North Africa (MENA) countries: A systematic review and meta-analysisMohsen Sedighi, Mohammad Hasan Shahabi, Alireza Amanollahi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 5, 2025
Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: A systematic review and meta-analysisSarah Pahlke, Lara A Kahale, Simin Mahinrad, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2025
Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settingsSebastian Palmqvist, Heather E Whitson, Laura A Allen, et al.
Science Translational Medicine|November 5, 2025
Beyond Alzheimer's disease-translating biomarker insights across CNS diseasesLinda S Brady, Simin Mahinrad, Rebecca M Edelmayer, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2025
Tau biology, biomarkers, and therapeuticsBess Frost, Hartmuth Kolb, Alicia Algeciras-Schimnich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 15, 2026
Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)Philippe Amouyel, Sandrine Andrieu, Angela Bradshaw, et al.
Pageof 4